Login to Your Account



OGS Gains European Approval Of Zavesca For Gaucher's Disease

By Nuala Moran


Wednesday, November 27, 2002
Oxford GlycoSciences plc said its lead product, Zavesca, a treatment for Gaucher's disease received marketing authorization from the European Commission and the company plans to launch the product on the European market in the spring. (Bioworld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription